Sequenom to Sell 5.5M Shares in Public Offering, Plans New MassArray Applications | GenomeWeb
NEW YORK (GenomeWeb News) – Sequenom filed a prospectus today with the US Securities and Exchange Commission to sell 5.5 million shares of common stock through the open market.
The San Diego-based firm said that it expects to realize net proceeds of around $73.4 million, assuming an offering price of $14.25 per share, which was its closing price on the Nasdaq on Friday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.